Kalaris Therapeutics, Inc. (KLRS) — Financial Flexibility Index
Kalaris Therapeutics, Inc. (KLRS) has a Financial Flexibility Index of -0.22x as of December 2025. Free cash flow of $-9.30 Million (operating CF $-9.32 Million minus capex $17.00K) represents 0% of total liabilities ($42.92 Million). Also explore Kalaris Therapeutics, Inc. (KLRS) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Kalaris Therapeutics, Inc. Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Kalaris Therapeutics, Inc. across 8 annual periods. Check asset resilience ratio of Kalaris Therapeutics, Inc. to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Kalaris Therapeutics, Inc. (2018–2025)
Year-by-year free cash flow to debt coverage for Kalaris Therapeutics, Inc.. For the full company profile including market capitalisation, see how much is Kalaris Therapeutics, Inc. worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.00x | $-42.78 Million | $-42.98 Million | $42.92 Million | ▲ +92.3% |
| 2024 | -12.92x | $-67.70 Million | $-67.70 Million | $5.24 Million | ▼ -4321.5% |
| 2023 | -0.29x | $-14.13 Million | $-14.13 Million | $48.35 Million | ▼ -2.1% |
| 2022 | -0.29x | $-9.78 Million | $-9.78 Million | $34.17 Million | ▲ +83.5% |
| 2021 | -1.73x | $-106.29 Million | $-106.32 Million | $61.33 Million | ▲ +49.2% |
| 2020 | -3.41x | $-60.58 Million | $-60.81 Million | $17.76 Million | ▼ -206.4% |
| 2019 | -1.11x | $-19.82 Million | $-20.16 Million | $17.80 Million | ▼ -314.1% |
| 2018 | 0.52x | $1.94 Million | $1.94 Million | $3.74 Million | — |